icer valuing a cure meeting: affordability and fair sharing of economic surplus
Published 4 years ago • 134 plays • Length 1:26:55Download video MP4
Download video MP3
Similar videos
-
1:28:42
icer valuing a cure meeting: increased uncertainty
-
5:55
icer valuing a cure meeting: key takeaways and next steps
-
46:09
icer valuing a cure meeting: welcome and opening remarks
-
55:05
icer valuing a cure meeting: time divergence between costs and benefits
-
1:03:24
icer valuing a cure meeting: questions about additional elements of value
-
1:03:33
icer ctaf public meeting on metachromatic leukodystrophy: voting questions
-
7:54
2. cea approach and icers
-
17:27
energy consumption of osmotically-assisted ro and low-salt-rejection ro for brine management
-
2:45
icer’s value assessments harm access for protected populations – what you need to know
-
1:09:13
vaf webinar
-
38:19
the economics of oxytetracycline (otc) applications and crop insurance.
-
1:14:37
perspectives on the cost effectiveness threshold in health care for the united states: webinar 5
-
1:07:13
icer's updated value assessment framework
-
46:14
updates to icer’s value assessment framework
-
2:05
icer and cost-effective health care
-
1:45
icer's use of the qaly and the evlyg (with captions)
-
1:50
icer video
-
2:54
limitations of icer’s value assessment framework tool
-
1:45:37
icer new england cepac public meeting on treatments for multiple sclerosis: policy roundtable
-
1:01:02
icer’s value assessment framework: an overview of the 2020 value framework
-
1:06:59
perspectives on the cost effectiveness threshold in health care for the united states: webinar 4